In its Series A announced today Glycomine, an early-stage biotech working on replacement therapies for rare diseases, raised $12 million with help from…

An entrepreneur who made his fortune building a $14 billion tech company is setting up a life science venture capital fund.

Evotec and the University of Oxford have teamed up to bridge the gap between academic research and industry.

An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…

A clutch of leading U.K. life sciences investors is pooling its resources to create a group with £1 billion ($1.2 billion) in assets.

Tel Aviv, Israel-based Therapix BioSciences has filed for a modest $12 million initial public offering as it looks to build up its portfolio of cannabinoid-…

ADC specialist NBE Therapeutics has raised CHF 20 million from investors including PPF Group and Boehringer Ingelheim Venture Fund

Turnstone Biologics will use its new cash pot to both boost and expand its pipeline of oncolytic viral immunotherapies with help from new investors OrbiMed and…

Venture Capital